Buy CISPLATIN INJECTION BP 1 MG CISPLATIN

Cisplatin Injection BP 1 MG is a chemotherapy medication used to treat various types of cancer. This intravenous solution is manufactured by Pfizer Canada ULC and is available in 10ML, 50ML, and 100ML pack sizes.

Strength

1 MG

Pack Size

10ML/50ML/100ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Cisplatin Injection BP 1 MG is primarily used in cancer treatment, often as part of a combination chemotherapy regimen. It works by interfering with the growth and spread of cancer cells. The specific uses of cisplatin may vary depending on the type and stage of cancer, as determined by a healthcare professional.

Side Effects

Common effects of cisplatin may include nausea, vomiting, and fatigue. Some patients may also experience kidney problems, hearing loss, or nerve damage. These effects can vary in severity and duration, and not everyone will experience them.

Precautions & Warnings

Cisplatin should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional regarding administration and storage. Patients should be monitored for signs of kidney damage, hearing loss, and nerve problems during treatment.

Avoid Interactions

Cisplatin may interact with other medications, including certain antibiotics, diuretics, and other chemotherapy drugs. It is important to inform a healthcare professional about all medications being taken to avoid potential interactions. Alcohol consumption should be avoided during treatment.

References

Frequently Asked Questions

Cisplatin is used in the treatment of various types of cancer, often as part of a combination chemotherapy regimen.

Cisplatin is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, kidney problems, hearing loss, and nerve damage.

Cisplatin may interact with other medications, so it is important to inform a healthcare professional about all medications being taken.

Cisplatin should be handled with care, and patients should be monitored for signs of kidney damage, hearing loss, and nerve problems during treatment.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.